This inventor holds 4 USPTO granted patents and 2 published patent applications, plus 2 CIPO patents and 2 EPO patents. Top assignee: B. Braun Melsungen Ag. Active years: 1999-2013.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 1999-2013
Title: Michael Boll: Innovator in Pharmaceutical Solutions
Introduction
Michael Boll is a notable inventor based in Melsungen, Germany. He has made significant contributions to the field of pharmaceuticals, particularly in the development of solutions for medical applications. With a total of 4 patents to his name, Boll's work has had a considerable impact on healthcare.
Latest Patents
Among his latest patents is a formulation involving hydroxyethylstarch. This invention describes a hydroxyethylstarch, a process for its preparation, and a pharmaceutical formulation that utilizes it. The formulation is designed for various medical applications, including volume replacement and improving macro- and microcirculation. Another significant patent is for a plasma-adapted full electrolyte solution. This balanced aqueous electrolyte solution is particularly suitable for intravenous and subcutaneous infusion, enhancing patient care in medical settings.
Career Highlights
Michael Boll is associated with B. Braun Melsungen AG, a leading company in the medical technology sector. His work at the company has allowed him to focus on innovative solutions that address critical healthcare needs. His contributions have been instrumental in advancing medical treatments and improving patient outcomes.
Collaborations
Throughout his career, Boll has collaborated with esteemed colleagues, including Andreas Fisch and Donat R Spahn. These partnerships have fostered a collaborative environment that encourages innovation and the sharing of ideas.
Conclusion
Michael Boll's contributions to the pharmaceutical industry exemplify the importance of innovation in healthcare. His patents reflect a commitment to improving medical solutions and enhancing patient care. His work continues to inspire advancements in the field.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
